These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15700180)

  • 21. Brain membrane phospholipid alterations in Alzheimer's disease.
    Pettegrew JW; Panchalingam K; Hamilton RL; McClure RJ
    Neurochem Res; 2001 Jul; 26(7):771-82. PubMed ID: 11565608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 31P magnetic resonance spectroscopy studies in schizophrenia.
    Williamson PC; Brauer M; Leonard S; Thompson T; Drost D
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):115-8. PubMed ID: 8888133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy.
    Richardson AJ; Cox IJ; Sargentoni J; Puri BK
    NMR Biomed; 1997 Oct; 10(7):309-14. PubMed ID: 9471121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study.
    Pettegrew JW; Panchalingam K; Klunk WE; McClure RJ; Muenz LR
    Neurobiol Aging; 1994; 15(1):117-32. PubMed ID: 8159258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease.
    Forlenza OV; Schaeffer EL; Gattaz WF
    J Neural Transm (Vienna); 2007 Feb; 114(2):231-8. PubMed ID: 17131232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in brain metabolism associated with agitation and depression in Alzheimer's disease.
    Tsai CF; Hung CW; Lirng JF; Wang SJ; Fuh JL
    East Asian Arch Psychiatry; 2013 Sep; 23(3):86-90. PubMed ID: 24088401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased phospholipase A2 activity in Alzheimer brains.
    Gattaz WF; Maras A; Cairns NJ; Levy R; Förstl H
    Biol Psychiatry; 1995 Jan; 37(1):13-7. PubMed ID: 7893853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients].
    Wu B; Song B; Zhou XP; Yang Y; Lei XZ; Jiang LL
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):338-41. PubMed ID: 17524264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T.
    Agarwal N; Sung YH; Jensen JE; daCunha G; Harper D; Olson D; Renshaw PF
    Bipolar Disord; 2010 Dec; 12(8):825-33. PubMed ID: 21176029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education?
    Aprahamian I; Martinelli JE; Cecato J; Izbicki R; Yassuda MS
    Int Psychogeriatr; 2011 Feb; 23(1):96-101. PubMed ID: 20678300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological profile of Alzheimer's disease in women: moderate and moderately severe cognitive decline.
    Garre-Olmo J; López-Pousa S; Vilalta-Franch J; Turon-Estrada A; Lozano-Gallego M; Hernández-Ferràndiz M; Gelada-Batlle E; Cruz-Reina MM; Morante-Muñoz V; Peralta-Rodríguez J
    Arch Womens Ment Health; 2004 Feb; 7(1):27-36. PubMed ID: 14963730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Rami L; Gómez-Ansón B; Bosch B; Sánchez-Valle R; Monte GC; Villar A; Molinuevo JL
    Dement Geriatr Cogn Disord; 2007; 24(4):274-9. PubMed ID: 17717413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regionally Distinct Alterations in Membrane Phospholipid Metabolism in Schizophrenia: A Meta-analysis of Phosphorus Magnetic Resonance Spectroscopy Studies.
    Haszto CS; Stanley JA; Iyengar S; Prasad KM
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Mar; 5(3):264-280. PubMed ID: 31748123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance spectroscopic changes in Alzheimer's disease.
    Pettegrew JW; Klunk WE; Panchalingam K; McClure RJ; Stanley JA
    Ann N Y Acad Sci; 1997 Sep; 826():282-306. PubMed ID: 9329700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.